Galectin Therapeutics Inc. (GALT)

NASDAQ: GALT · Real-Time Price · USD

Compare

5.49

-0.45 (-7.58%)

At close: Dec 10, 2025, 4:00 PM EST

5.74

+0.25 (4.47%)

After-hours: Dec 10, 2025, 6:55 PM EST

Galectin Therapeutics Market Cap

Galectin Therapeutics has a market cap or net worth of $353.96 million as of December 10, 2025. Its market cap has increased by 96.64% in one year.

Market Cap

353.96M

Enterprise Value

468.48M

1-Year Change

96.64%

Ranking

#3360

Market Cap Chart

Since September 10, 2003, Galectin Therapeutics's market cap has increased from $106.80M to $353.96M, an increase of 231.42%. That is a compound annual growth rate of 5.54%.

Market Cap History

Date	Market Cap	% Change
Nov 26, 2025	371.40M	358.52%
Dec 31, 2024	81.00M	-21.13%
Dec 29, 2023	102.70M	52.83%
Dec 30, 2022	67.20M	-45.28%
Dec 31, 2021	122.80M	-3.99%
Dec 31, 2020	127.90M	-21.39%
Dec 31, 2019	162.70M	15.31%
Dec 31, 2018	141.10M	18.57%
Dec 29, 2017	119.00M	313.19%
Dec 30, 2016	28.80M	-26.53%
Dec 31, 2015	39.20M	-48.96%
Dec 31, 2014	76.80M	-48.11%
Dec 31, 2013	148.00M	352.60%
Dec 31, 2012	32.70M	-55.81%
Dec 30, 2011	74.00M	32.14%
Dec 31, 2010	56.00M	288.89%
Dec 31, 2009	14.40M	234.88%
Dec 31, 2008	4.30M	-84.81%
Dec 31, 2007	28.30M	111.19%
Dec 29, 2006	13.40M	-83.91%
Dec 30, 2005	83.30M	21.96%
Dec 31, 2004	68.30M	-23.94%
Dec 31, 2003	89.80M	-15.92%
Sep 10, 2003	106.80M	-

View and export this data all the way back to 2003. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	893.23B
Johnson & Johnson	485.76B
AbbVie	394.34B
UnitedHealth Group	293.15B
AstraZeneca	280.30B
Novartis AG	253.21B
Merck & Co.	245.55B
Thermo Fisher Scientific	213.48B

Market Cap Rankings